Target intelligence / Profile preview

CAPN9 antisense RNA 1 (CAPN9-AS1)

Target: CAPN9-AS1
Molecular classification: Long non-coding RNA, Other

Overview

CAPN9 antisense RNA 1 (CAPN9-AS1) is a gene producing a long non-coding RNA that is classified in the lncRNA category. It does not encode a protein and is transcribed in the antisense direction relative to the CAPN9 protein-coding gene. Current public summaries do not attribute a specific biological function, disease relevance, or therapeutic target status to CAPN9-AS1[4][7]. Its nomenclature and classification are established in gene databases, but functional and clinical information is lacking.

Other names: CAPN9-AS1

Biological functions

Unknown

Disease associations

Unknown

Beyond the preview

Go deeper on CAPN9 antisense RNA 1 (CAPN9-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAPN9 antisense RNA 1 (CAPN9-AS1).

Explore the full profile